Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Zucman

Showing results (21-30 of 72) with videos related to

Pageof 8
Sort By:
BMC Infectious Diseases|May 11, 2019
Patients' high acceptability of a future therapeutic HIV vaccine in France: a French paradox?Svetlane Dimi, David Zucman, Olivier Chassany, et al.
Scandinavian Journal of Infectious Diseases|March 13, 2013
Efficacy, safety, and pharmacokinetics of once-daily boosted darunavir in pretreated HIV-infected patientsDavid Zucman, P De Truchis, Gilles Peytavin, et al.
Vaccine|May 7, 2024
Insufficient vaccine coverage and vaccine hesitancy in people living with HIV: A prospective study in outpatient clinics in the Paris regionAgnieszka Kolakowska, Esaïe Marshall, Evguenia Krastinova, et al.
Plos One|September 30, 2024
Acceptability determinants of a proposal to reduce antiretroviral treatment to an oral two-drug regimen among patients living with HIV and physicians in FranceAnne-Sophie Petit, Clotilde Allavena, David Zucman, et al.
Plos One|July 23, 2013
Sexually-transmitted/founder HIV-1 cannot be directly predicted from plasma or PBMC-derived viral quasispecies in the transmitting partnerPierre Frange, Laurence Meyer, Matthieu Jung, et al.
Plos One|May 3, 2011
CD4 dynamics over a 15 year-period among HIV controllers enrolled in the ANRS French observatoryFaroudy Boufassa, Asier Saez-Cirion, Jérome Lechenadec, et al.
BMJ Open|June 5, 2024
Development of a risk prediction score for screening for HBV, HCV and HIV among migrants in France: results from a multicentre observational study (STRADA study)Martin Duracinsky, Issifou Yaya, Lisa Yombo-Kokule, et al.
AIDS Research and Therapy|March 16, 2022
HCV cure: an appropriate moment to reduce cannabis use in people living with HIV? (ANRS CO13 HEPAVIH data)Tangui Barré, Patrick Mercié, Caroline Lions, et al.
BMC Infectious Diseases|November 8, 2011
Mycobacterium genavense as a cause of subacute pneumonia in patients with severe cellular immunodeficiencyBlandine Rammaert, Louis-Jean Couderc, Elisabeth Rivaud, et al.
BMC Health Services Research|June 16, 2022
Electronic medical record alert increases HIV screening rates: the Foch hospital pilot POP-up projectAlexandre Vallée, Dimi Sveltlane, Julie Trichereau, et al.
Pageof 8

Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
BMC Infectious Diseases|May 11, 2019
Patients' high acceptability of a future therapeutic HIV vaccine in France: a French paradox?Svetlane Dimi, David Zucman, Olivier Chassany, et al.
Scandinavian Journal of Infectious Diseases|March 13, 2013
Efficacy, safety, and pharmacokinetics of once-daily boosted darunavir in pretreated HIV-infected patientsDavid Zucman, P De Truchis, Gilles Peytavin, et al.
Vaccine|May 7, 2024
Insufficient vaccine coverage and vaccine hesitancy in people living with HIV: A prospective study in outpatient clinics in the Paris regionAgnieszka Kolakowska, Esaïe Marshall, Evguenia Krastinova, et al.
Plos One|September 30, 2024
Acceptability determinants of a proposal to reduce antiretroviral treatment to an oral two-drug regimen among patients living with HIV and physicians in FranceAnne-Sophie Petit, Clotilde Allavena, David Zucman, et al.
Plos One|July 23, 2013
Sexually-transmitted/founder HIV-1 cannot be directly predicted from plasma or PBMC-derived viral quasispecies in the transmitting partnerPierre Frange, Laurence Meyer, Matthieu Jung, et al.
Plos One|May 3, 2011
CD4 dynamics over a 15 year-period among HIV controllers enrolled in the ANRS French observatoryFaroudy Boufassa, Asier Saez-Cirion, Jérome Lechenadec, et al.
BMJ Open|June 5, 2024
Development of a risk prediction score for screening for HBV, HCV and HIV among migrants in France: results from a multicentre observational study (STRADA study)Martin Duracinsky, Issifou Yaya, Lisa Yombo-Kokule, et al.
AIDS Research and Therapy|March 16, 2022
HCV cure: an appropriate moment to reduce cannabis use in people living with HIV? (ANRS CO13 HEPAVIH data)Tangui Barré, Patrick Mercié, Caroline Lions, et al.
BMC Infectious Diseases|November 8, 2011
Mycobacterium genavense as a cause of subacute pneumonia in patients with severe cellular immunodeficiencyBlandine Rammaert, Louis-Jean Couderc, Elisabeth Rivaud, et al.
BMC Health Services Research|June 16, 2022
Electronic medical record alert increases HIV screening rates: the Foch hospital pilot POP-up projectAlexandre Vallée, Dimi Sveltlane, Julie Trichereau, et al.
Pageof 8